Xavier Becerra, President Joe Biden’s outgoing Health and Human Services secretary, is lamenting Americans’ abysmal distrust in federal health agencies while
BECERRA’S FINAL ACT — During the unveiling of his official portrait on Tuesday, HHS Secretary Xavier Becerra, who will soon depart the agency, highlighted the record number of people who have signed up for health insurance since he took the helm of the sprawling agency — and President Joe Biden’s role in it, Chelsea reports.
The Biden administration unveiled its list of 15 drugs, which include GLP-1 drugs, for the second annual round of drug price negotiations, made possible through the Inflation Reduction Act (IRA).
Sen. Ted Cruz supports Pam Bondi's confirmation as attorney general, calling her Trump's most crucial nominee and praising her strong hearing performance.
President-elect Donald Trump will likely travel to California next week to view the aftermath of the devastating wildfires in the greater Los Angeles area, he told NBC News' "Meet the Press" moderator Kristen Welker in a phone interview Saturday.
US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company's bird flu vaccine, as fears of a new pandemic grow.
Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers, the Biden administration said Friday.
The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing the selection two weeks ahead of schedule.
US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company's bird flu vaccine, as fears of a new pandemic grow.
The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.
The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers.
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations, the Biden administration announced Friday.